ストックスクリーナーアプリを入手
1.48
3.90%
-0.06
アフターアワーズ：
1.48
前日終値:
$1.54
開ける：
$1.49
24時間の取引高:
52,505
Relative Volume:
0.10
時価総額：
$6.07M
収益：
$502.40K
当期純損益:
$-7.91M
株価収益率:
-0.1484
EPS:
-9.972
ネットキャッシュフロー:
$-4.32M
1週間 パフォーマンス:
+6.47%
1か月 パフォーマンス:
+4.96%
6か月 パフォーマンス:
-19.57%
1年 パフォーマンス:
-76.32%
1日の値動き範囲:
$1.44
$1.54
1週間の範囲:
$1.34
$1.56
52週間の値動き範囲:
$1.215
$12.45
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
名前
60 Degrees Pharmaceuticals Inc
セクター
電話
202-327-5422
住所
1025 CONNECTICUT AVENUE NW, WASHINGTON
SXTP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.48 | 6.32M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc (SXTP) 最新ニュース
Will 60 Degrees Pharmaceuticals Inc. rebound enough to break evenJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
What does recent volatility data suggest for 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Top Decliners & AI Forecasted Entry and Exit Points - newser.com
Using Python tools to backtest 60 Degrees Pharmaceuticals Inc. strategiesTrade Entry Report & AI Enhanced Trading Alerts - newser.com
Real time breakdown of 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performanceJuly 2025 Opening Moves & Community Driven Trade Alerts - newser.com
How buybacks impact 60 Degrees Pharmaceuticals Inc. stock valueWeekly Market Report & Daily Technical Forecast Reports - newser.com
Sector ETF performance correlation with 60 Degrees Pharmaceuticals Inc.Weekly Trade Recap & Intraday High Probability Alerts - newser.com
Why retail investors pile into 60 Degrees Pharmaceuticals Inc. stockJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
Is now a turning point for 60 Degrees Pharmaceuticals Inc. Equity WarrantWeekly Trade Report & Safe Capital Growth Plans - newser.com
What Fibonacci levels say about 60 Degrees Pharmaceuticals Inc. Equity Warrant reboundJuly 2025 Final Week & Real-Time Volume Spike Alerts - newser.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock gaining market shareWeekly Market Summary & Target Return Focused Stock Picks - newser.com
Using RSI to spot recovery in 60 Degrees Pharmaceuticals Inc.Quarterly Trade Review & Long-Term Safe Investment Ideas - newser.com
Analyzing recovery setups for 60 Degrees Pharmaceuticals Inc. investorsRate Cut & Fast Entry High Yield Tips - newser.com
Is this a good reentry point in 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Earnings Surprises & Community Consensus Trade Alerts - newser.com
Analyzing Aurinia Pharmaceuticals (NASDAQ:AUPH) & 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
What candlestick patterns are forming on 60 Degrees Pharmaceuticals Inc.July 2025 Retail & Daily Chart Pattern Signals - newser.com
Tools to assess 60 Degrees Pharmaceuticals Inc. Equity Warrant’s risk profile2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com
What MACD and RSI say about 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Patterns & Free Community Consensus Stock Picks - newser.com
News impact scoring models applied to 60 Degrees Pharmaceuticals Inc. Equity WarrantGold Moves & AI Enhanced Trading Signals - newser.com
Risk adjusted return profile for 60 Degrees Pharmaceuticals Inc. analyzedJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
Earnings visualization tools for 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com
Volume spikes in 60 Degrees Pharmaceuticals Inc. stock – what they meanWeekly Profit Summary & Verified Entry Point Signals - newser.com
60 Degrees Pharmaceuticals Inc (SXTP) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):